Sarepta Surprised By CRL For Exon 53-Skipping DMD Drug Golodirsen

 
• By Mandy Jackson
Accept - Refuse_529502731_1200.jpg
US FDA approval never is certain, but golodirsen's rejection was surprising. • Source: Shutterstock

More from New Products

More from Scrip